Skip to main content
FinSpry Logo
FinSpry
UTHR logo
UTHR
(NASDAQ)
United Therapeutics Corporation
$503.86-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

United Therapeutics Corporation (UTHR) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for United Therapeutics Corporation stock.

Analyst Consensus Rating

Investment consensus from 4 professional research analysts

Consensus Rating

Buy
Based on 4 unique analysts
(5 total ratings in last 90 days)
Low Confidence∞:1 Buy/Sell

Average Price Target

$677.00
↑ 33.58% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest UTHR Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Roger Song
Jefferies
BuyMaintains
$733.00 → $714.00
Jason Gerberry
BofA Securities
HoldReiterates
$620.00 → $613.00
Lisa Walter
RBC Capital
BuyMaintains
$701.00 → $704.00
Roanna Ruiz
Leerink Partners
BuyMaintains
-
Roanna Ruiz
Leerink Partners
BuyReiterates
$700.00

Frequently Asked Questions

What is the analyst consensus rating for UTHR?

The analyst consensus rating for UTHR is "Buy" based on 4 analyst recommendations.

What is the average price target for UTHR?

The average 12-month price target for UTHR is $677.00, representing an upside of 33.6% from the current price of $506.82.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.